nemoci-sympt/HEMATOLOGIE/lymfom-hodgkinuv/zlepsujici
Adriamycin, bleomycin, vinblastine and dacarbazine (ABVD)
- Chemotherapy regimen successful in the majority of early stage HL patients
- www.sciencedirect.com/science/article/pii/S0753332220300019
Bleomycin, etoposide, adriamycin, cyclophosphamide, oncovin, procarbazine and prednisone (BEACOPP)
- For advanced stage patients gives better survival than ABVD
- Toxicity is significantly higher for BEACOPP-treated as compared to ABVD-treated patients
- www.sciencedirect.com/science/article/pii/S0753332220300019
CTLA-4 inhibitors
CTLA-4 monoclonal antibodies
- Ipilimumab
- Avelumab
- Durmalumab
- Consequence is usually about 50% irreversible in immune-related endocrine toxicities. Those toxicities include hypophysitis, adrenal insufficiency, type 1 diabetes mellitus, and thyroid dysfunctions
Celastrol
- Celastrol (tripterine) is a chemical compound isolated from the root extracts of Tripterygium wilfordii (Thunder god vine) and Tripterygium regelii (Regel's threewingnut).
- Inhibits proliferation, induces apoptosis and growth arrest of KMH2 via caspase3/7 activation
- Whereas L428 cells were recalcitrant to this compound
- Difference in cellular responses of either KMH2 or L428 to the same drug may be related to different subtypes of cHL
- KMH2 is a cellular model of MC-cHL,
- L428 of nodular sclerosis cHL.
City University of New York (CUNY), CUNY Academic Works, Publications and Research Bronx Community College 2020, CUNY Bronx Community College at.al.
- Celastrol, an anti-inflammatory compound
- Recognized HSP90 inhibitor, in Hodgkin and Reed–Sternberg cell lines
- KM-H2 cells, celastrol inhibited cell proliferation, induced G0/G1 arrest, and triggered apoptosis through the activation of caspase-3/7.
- L428 cells exhibited resistance to the compound.
- www.mdpi.com/1422-0067/19/3/836/htm
Curcumin formulated in solid lipid nanoparticles
- Has enhanced efficacy in Hodgkin's lymphoma in mice
- When given in combination with bleomycin, doxorubicin and vinblastine, curcumin showed an additive growth inhibitory effect
- We speculate that curcumin, when appropriately formulated, is a promising adjuvant agent for the treatment of HL and merits further evaluation
- Curcumin formulated in solid lipid nanoparticles (SLNs) improves its plasma levels.
- Curcumin formulated in SLN reduces Hodgkin's lymphoma (HL) xenograft growth.
- Curcumin reduces the levels of inflammatory cytokines in HL cells.
- Curcumin enhances the growth inhibitory effect of HL chemotherapeutic drugs.
Curcumin (diferuloylmethane)
- Lipid-soluble yellow compound isolated from the rhizomes of the plant Curcuma longa
- Induces cell-arrest and apoptosis
- In association with the inhibition of constitutively active NF-?B and STAT3 pathways in Hodgkin's lymphoma cells
- curcumin caused cell cycle arrest in G2-M and a significant reduction (80–97%) in H-RS cell viability.
- curcumin triggered cell death by apoptosis
- Activation of caspase-3 and caspase-9
- Changes in nuclear morphology and phosphatidylserine translocation
- Potential use of curcumin as a therapeutic agent for patients with HL
© 2008 Wiley-Liss, Inc.
- onlinelibrary.wiley.com/doi/10.1002/ijc.23477
- curcumin can inhibit growth of HL cell lines and increases the sensitivity of these cells for cisplatin. In this review we summarize curcumin activities with special focus on possible activities against HL cells.
- journals.sagepub.com/doi/full/10.4137/CGM.S11113
Ethacrynic acid (EA) and its derivatives
- Inhibit the GST alpha, micro, pí subclasses
- By binding to the substrate-binding site
- By depleting enzymatic cofactors
Inhibition of HSP90
- Induces apoptosis in Hodgkin's lymphoma cell lines
Luteolin
- Induces Cytotoxicity in Mix Cellularity Classical Hodgkin's Lymphoma via Caspase Activated-cell Death
- Luteolin (3,4,5,7-tetrahydroxy flavone, LUT)
- Flavonoid found in common foods demonstrated in studies in multiple human malignancies such as lung, breast, glioblastoma, prostate, colon, and pancreatic cancers
- Trigger apoptosis
- Inhibit cell growth,
- Stimulate cell cycle arrest
- Disrupt metastasis and cell migration
- Dietary intake of flavonoids was associated with reduced risk of occurrence non-Hodgkin’s lymphoma
- LUT suppresses the growth of cHL, in vitro
- Both cell lines, KMH2 and L428, showed dose-dependent cell growth responses to LUT treatment
- LUT in part, suppresses viability of KMH2 via caspase activation.
City University of New York (CUNY), CUNY Academic Works, Publications and Research Bronx Community College 2020, CUNY Bronx Community College at.al.
Melatonin
- Triggers autophagic cell death by regulating RORC in Hodgkin lymphoma
- Melatonin exerted anti-tumor activities in Hodgkin lymphoma via inhibiting cell proliferation and promoting cell apoptosis.
- Melatonin treatment induced autophagy in Hodgkin lymphoma cells.
- Melatonin induces autophagy by increasing the expression of RORC.
- Mel treatment increased expression of LC3-II and decreased p62 proteins with the enhanced production of autolysosome
- Induced activation of autophagy
- Together with autophagy inhibitors 3-MA or CQ exacerbated the damage effect of Mel in HL cells
- Autophagy plays a protective role in this process.
- Mel treatment increased the expression of G protein-coupled receptors MT2 and retinoic acid-related orphan receptors (RORs), eg. RORA, RORB and RORC.
- While RORC has the highest increase in Mel treated HL cells.
- RORC overexpression induced autophagy activation.
- Therefore, Mel showed tumor-suppressive role due to an increased level of RORC induced autophagy in HL.
- www.sciencedirect.com/science/article/pii/S0753332220300019
Nano-curcumin
- Relatively high cytotoxic effect on MCF7 breast cancer cells, suppressing the expression of cyclinD1, a critical gene in the development and metastasis of breast cancer
- www.sciencedirect.com/science/article/pii/S0753332220300019
PD-L1 inhibitors
PD-L1 inhibitory
- PD-L1 (or B7-H1) is a protein produced by cancer cells
- Interacts with PD-1
- Suppresses activated T-cell from engaging with cancer cells
- PD-L1 ligand activity may also induce apoptosis of T-cells.
- PD-L1 overexpression is observed in melanoma, pancreatic, lung, and other types of cancer cells.
www.ncbi.nlm.nih.gov/pmc/articles/PMC6949899/
Resveratrol
Extract of Anoectochilus formosanus Hayata
- A traditional anti-inflammatory herbal medicine,
- Inhibited constitutively expressed PD-L1 and protein accumulation
- Inhibited cancer proliferation
www.ncbi.nlm.nih.gov/pmc/articles/PMC6949899/
- Anoectochilus formosanus extract (AFE)
- Inhibits the constitutive expression of PD-L1 and accumulation of its protein
- Induces the expression of pro-apoptotic genes but inhibits the expression of proliferative and metastatic genes
- AFE induces anti-proliferation in cancer cells
- AFE reduced blood glucose concentrations as well as metformin
- Producing a hypoglycemic effect, ROS scavenging, and PD-L1 suppression.
- www.ncbi.nlm.nih.gov/pmc/articles/PMC6949899/
Pembrolizumab and nivolumab
- Thyroid abnormalities like thyrotoxicosis, hypothyroidism, painless thyroiditis, and even thyroid storms are more commonly related to applying anti-PD-1 antibodies
Curcumin
- Inhibit CSN5 to diminish PD-L1 expression in cancer cells
- curcumin inhibits the expression of PD-L1 and p-STAT3Y705 both in vitro and in vivo
- Treatment can change the immunosuppressive tumor microenvironment.
- curcumin promoted an antitumor immune response effectively in tongue squamous cell carcinoma
- Bisdemethoxycurcumin
- A naturally produced curcumin dimethoxy derivative
- Reduce PD-L1 expression to provide a promising environment for T-cell responses against bladder cancer
- Combination of curcumin and apigenin
- Suppresses cancer cell growth
- Induces pro-apoptotic effects in melanoma cells
Apigenin
- Inhibited IFN-gamma-induced PD-L1 up-regulation
- Via significantly inhibiting STAT1 phosphorylation
- Combined treatment sensitizes cancer cells to anti-CTLA4 therapy
Panobinostat
- Pan-deacetylase inhibitor
- Induces cell death
- Synergizes with everolimus in Hodgkin lymphoma cell lines
- Combining panobinostat with the mTOR inhibitor everolimus (RAD001)
- Inhibited panobinostat-induced mTOR activation
- Enhanced panobinostat antiproliferative effects.
- Panobinostat is a potent deacetylase inhibitor against Hodgkin lymphoma–derived cell lines
- ashpublications.org/blood/article/119/17/4017/29874/The-pan-deacetylase-inhibitor-panobinostat-induces
Resveratrol
- Mediated apoptosis of hodgkin lymphoma cells involves SIRT1 inhibition and FOXO3a hyperacetylation
- Resveratrol (RSV), a plant-derived stilbene
- Induces cell death in Hodgkin lymphoma (HL)-derived L-428 cells in a dose-dependent manner
- (IC50 = 27 µM, trypan blue exclusion assay)
- At a lower range (25 µM)
- RSV treatment for 48 hr causes arrest in the S-phase of the cell cycle
- At a higher concentration range (50 µM)
- Apoptosis can be detected, with activation of caspase-3.
- The histone/protein deacetylase SIRT1 has been described as a putative target of RSV action in other model systems, even though its role in cancer cells is still controversial.
- pubmed.ncbi.nlm.nih.gov/22833338/
- resveratrol and other herbal medicines suppress PD-L1 accumulation and reduce diabetic effects !!!
- www.ncbi.nlm.nih.gov/pmc/articles/PMC6949899/
Retinoids
- Modulate cell growth and differentiation in a variety of human tumors.
- Particularly effective in T-cell and Hodgkin lymphoma cell lines
- Inhibit cell growth by arresting cells in the G1-phase or inducing apoptosis
- Reduce the expression of antiapoptotic bcl-2 protein
- Upregulate proapoptotic bax-proteins
- Involved in the retinoic acid-induced pathway in T-cell lymphoma were identified
- Transcription factors
- Chaperones
- 90kDa heat shock protein
- Ion channels
- Genes that code for cytoskeletal proteins
- Retinoic acid (RA)-induced apoptosis may be mediated by way of a cascade of genes that is related to the various cellular functions
Bexarotene
- RXR-selective retinoid
- Induces in vitro apoptosis in CTCL cell lines
- Without inhibiting DNA or inducing differentiation that is associated more with RAR agonists
- Induced apoptosis of CTCL cells,
- Suppressed the expression of RXR and RAR alpha proteins and mRNA,
- Decreased the levels of proapoptotic proteins survivin,
- Activated caspace-3
- But did not effect expression of Fas/Fas ligand and bcl-2 proteins
- www.sciencedirect.com/science/article/abs/pii/S0889858803001072
Roscovitine
- Cyclin-dependent kinase inhibitor
- Might be also a potential anticancer agent for treatment of HL.
- Induces cell-cycle arrest and sensitizes HL cells to apoptosis
- Agents which increase cytotoxic drug sensitivity of HL
- Might be a treatment option for patients with chemoresistant HL.
- ar.iiarjournals.org/content/36/8/3905
Synthetic HDL nanoparticles
- Killed B-cell lymphoma, the most common form of the disease, in cultured human cells
- And inhibited human B-cell lymphoma tumor growth in mice.
- B-cell lymphoma is dependent on the uptake of natural HDL -- short for high-density lipoprotein -- from which it derives fat content, such as cholesterol.
- Five nanometer gold particle at its core
- When the nanoparticle is incubated with human B-cell lymphoma cells or used to treat a mouse with the human tumor
- Socks lymphoma with a double whammy
- Gold particle’s spongy surface sucks out its cholesterol while the gold core prevents the cell from absorbing more cholesterol typically carried in the core of natural HDL particles.
- Heavily focused on developing nanoparticles that could remove cholesterol from cells, especially those involved in heart disease
- To by mohly být třeba cyklodextriny !!!
- Nanoparticle without drugs was just as effective at killing the B-cell lymphoma cells.
- Lymphoma cells in patients had an overproduction of these HDL receptors compared to normal lymphocytes.
Vorinostat
- Expression of histone deacetylase 6 (HDAC6) is also particularly high in HL.
- HDAC inhibitor inhibits cell proliferation and induces changes in the gene expression pattern of HL cells.
- Vorinostat increased sensitivity of HL cell lines to chemotherapy, i.e. cisplatin
- ar.iiarjournals.org/content/36/8/3905
methyl-ß-cyclodextrin
- Antitumor effects against primary effusion lymphoma
- Via the depletion of cholesterol from lipid rafts
- pubmed.ncbi.nlm.nih.gov/25446086/